Successful Treatment of Hepatitis C Virus Infection Using Direct-Acting Antiviral Agents (DAAs) in Adolescents with Kidney Transplantation: A Case Series

References

• Dzekova-Vidimliski P, Sikole A. Hepatitis C virus infection in kidney transplant patients: current treatment options. Exp Clin Transplant. 2017;15:587–593.29219790
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9:S1.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes Hepatitis C Work Group. KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl. 2018;8(3):91. doi:10.1016/j.kisu.2018.06.001
   Web of Science ®Google Scholar
• Fernández I, Muñoz-Gómez R, Pascasio JM, et al. Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C. J Hepatol. 2017;13(4):1225. doi:10.1016/j.jhep.2016.12.020
   Web of Science ®Google Scholar
• Indolfi G, Thorne C, El Sayed MH, Giaquinto C, Gonzalez-Peralta RP. The challenge of treating children with hepatitis C virus infection. J Pediatr Gastroenterol Nutr. 2017;64(6):851–854. doi:10.1097/MPG.000000000000158928362694
   PubMed Web of Science ®Google Scholar
• Kementerian Kesehatan Republik Indonesia. 150 ribu orang potensial alami hepatitis kronis; 2017 Available from: https://www.kemkes.go.id/article/view/17072800006/150-ribu-orang-potensial-alami-hepatitis-kronis.html. Accessed 1023, 2019.
   Google Scholar
• Youssef DM, Abdo H, Alakhras A, Adham T, Mohamoud AH. Hepatitis C in children with chronic kidney disease: a single-center, Egypt. Saudi J Kidney Dis Transpl. 2017;28:102. doi:10.4103/1319-2442.19816128098110
   PubMed Web of Science ®Google Scholar
• Johnson DW, Dent H, Yao Q, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant. 2008;24:1598–1603. doi:10.1093/ndt/gfn68419096083
   PubMed Web of Science ®Google Scholar
• Ambarsari CG, Trihono PP, Kadaristiana A, et al. Five-year experience of continuous ambulatory peritoneal dialysis in children: a single center experience in a developing country. Med J Indones. 2019;28(4):329–337. doi:10.13181/mji.v28i4.3807
   Web of Science ®Google Scholar
• Ambarsari CG, Bermanshah EK, Putra MA, Rahman FHF, Pardede SO. Effective management of peritoneal dialysis-associated hydrothorax in a child: a case report. Case Rep Nephrol Dial. 2020;10(1):18–25. doi:10.1159/00050611932232056
   PubMed Web of Science ®Google Scholar
• Ambarsari CG, Rahman FHF, Bermanshah EK, Kadaristiana A. An unusual case of peritoneal dialysis twisted catheter in a child. J Indones Med Assoc. 2020;70(2):27–31.
   Google Scholar
• Ambarsari CG, Mushahar L, Kadaristiana A, Hidayati EL. Dressing versus non-dressing technique for exit-site care in children on chronic ambulatory peritoneal dialysis: a pilot retrospective cohort. Med J Indones. 2020.
   Web of Science ®Google Scholar
• Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005;5(3):215. doi:10.1038/nri157315738952
   PubMed Web of Science ®Google Scholar
• Gutierrez JA, Lawitz EJ, Poordad F. Interferon free, direct acting antiviral therapy for chronic hepatitis C. J Viral Hepat. 2015;22(11):861–870. doi:10.1111/jvh.1242226083155
   PubMed Web of Science ®Google Scholar
• Wong G, Coates T. To transplant early or treat first? A dilemma for hepatitis C–positive recipients. Kidney Int. 2019;96(3):535–539. doi:10.1016/j.kint.2019.02.02431113678
   PubMed Web of Science ®Google Scholar
• Kwo PY, Badshah MB. New hepatitis C virus therapies: drug classes and metabolism, drug interactions relevant in the transplant settings, drug options in decompensated cirrhosis, and drug options in end-stage renal disease. Curr Opin Organ Transplant. 2015;20(3):235–241. doi:10.1097/MOT.000000000000019825944238
   PubMed Web of Science ®Google Scholar
• Chopra A, Klein PL, Drinnan T, Lee SS. How to optimize HCV therapy in genotype 1 patients: management of side effects. Liver Int. 2013;33:30–34. doi:10.1111/liv.1208023286843
   PubMed Web of Science ®Google Scholar
• Abdel Ghaffar TY, El Naghi S, Abdel Gawad M, et al. Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C genotype 4. J Viral Hepat. 2019;26(2):263–270. doi:10.1111/jvh.1303230380158
   PubMed Web of Science ®Google Scholar
• Hill AM, Nath S, Simmons B. The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries. J Virus Erad. 2017;3(4):117.28758018
   PubMed Web of Science ®Google Scholar
• Ambarsari CG, Sindih RM, Saraswati M, Trihono PP. Delayed admission and management of pediatric acute kidney injury and multiple organ dysfunction syndrome in children with multiple wasp stings: a case series. Case Rep Nephrol Dial. 2019;9(3):137–148. doi:10.1159/00050404331828077
   PubMed Web of Science ®Google Scholar
• Ambarsari CG, Cahyadi D, Sari L, et al. Late diagnosis of Lesch–Nyhan disease complicated with end-stage renal disease and tophi burst: a case report. Ren Fail. 2020;42(1):113–121. doi:10.1080/0886022X.2020.171380531985336
   PubMed Web of Science ®Google Scholar
• Ambarsari CG, Trihono PP, Kadaristiana A, et al. Low-dose maintenance intravenous iron therapy can prevent anemia in children with end-stage renal disease undergoing chronic hemodialysis. Int J Nephrol. 2020.
   Web of Science ®Google Scholar
• GDP per capita (current US$). 2018 Available from: https://data.worldbank.org/indicator/ny.gdp.pcap.cd. Accessed 1111, 2019.
   Google Scholar
• Rachel Nall R. How much does hepatitis C treatment cost? 2018 Available from: https://www.medicalnewstoday.com/articles/323767.php-drug-types-and-costs. Accessed 1111, 2019.
   Google Scholar
• Xue Y, Zhang L-X, Wang L, Li T, Qu Y-D, Liu F. Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. World J Gastroenterol. 2017;23(32):5969. doi:10.3748/wjg.v23.i32.596928932089
   PubMed Web of Science ®Google Scholar
• Hanno AH, Hamouda S, Abdelgawad M, Aboelkheir H, Ahmed M. Comparison between safety and efficacy of two treatment regimens for pediatric patients with chronic hepatitis C virus infection: sofosbuvir/ledipasvir versus sofosbuvir/daclatasvir regimen. Acta Sci GI Disord. 2019;2(7):3–7. doi:10.31080/ASGIS.2019.02.0069
   Google Scholar
• Transplant BC. Clinical guidelines for transplant medications. Vol AMB.03.007 Rev11: British Columbia Transplant; 2019 Available from: http://www.transplant.bc.ca/Documents/HealthProfessionals/Clinicalguidelines/ClinicalGuidelinesforTRANSPLANTMEDICATIONS.pdf.
   Google Scholar
• Andrews LM, Li Y, De Winter BCM, et al. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. Expert Opin Drug Metab Toxicol. 2017;13(12):1225–1236. doi:10.1080/17425255.2017.139541329084469
   PubMed Web of Science ®Google Scholar
• Xia T, Zhu S, Wen Y, et al. Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis. Drug Des Dev Ther. 2018;12:417. doi:10.2147/DDDT.S149340
   PubMed Web of Science ®Google Scholar
• Fernández‐Ruiz M, Polanco N, García‐Santiago A, et al. Impact of anti‐HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid term follow up in a single center cohort study. Transpl Int. 2018;31(8):887–899. doi:10.1111/tri.1311829356211
   PubMed Web of Science ®Google Scholar
• Lu Z, Bonate P, Keirns J. Population pharmacokinetics of immediate‐and prolonged‐release tacrolimus formulations in liver, kidney and heart transplant recipients. Br J Clin Pharmacol. 2019;85(8):1692–1703. doi:10.1111/bcp.1395230950096
   PubMed Web of Science ®Google Scholar
• Palepu S, Prasad GVR. New-onset diabetes mellitus after kidney transplantation: current status and future directions. World J Diabetes. 2015;6(3):445. doi:10.4239/wjd.v6.i3.44525897355
   PubMed Web of Science ®Google Scholar